GlassScriptPhysician profile
John-Paul Pham
NPI 1841491503
$7,976.08
in general payments reported to CMS, 2019-2025
33 companies · $2,084 in 2025
The $2,084 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $171 · 2021: $719 · 2022: $1,656 · 2023: $1,346 · 2024: $1,597 · 2025: $2,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,007 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,006.87 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,899.24 | 2019-2025 | Watchman Flx, Versacross Access Solution, Watchman |
| Abiomed | $1,045.31 | 2019-2025 | Impella |
| Abbott Laboratories | $637.09 | 2019-2025 | Mitraclip, Amplatzer Amulet, Accent |
| Cvrx, INC. | $482.21 | 2020-2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $470.99 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $404.46 | 2021-2025 | Farxiga |
| Amgen INC. | $282.36 | 2021-2025 | Repatha, Repatha |
| Stryker Corporation | $272.37 | 2025 | Clottriever Bold Catheter, Flowtriever, Flowsaver |
| Shockwave Medical, INC | $254.16 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $200.93 | 2022-2023 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.19 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $184.48 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $177.17 | 2022-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Janssen Pharmaceuticals, INC | $173.92 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.15 | 2021-2025 | Jardiance |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $152.48 | 2020-2024 | Indigo System, Penumbra System |
| Novartis Pharmaceuticals Corporation | $145.36 | 2019-2025 | |
| Pfizer INC. | $138.31 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $137.58 | 2021-2025 | Verquvo |
| Opsens INC. | $122.01 | 2019 | |
| Bard Peripheral Vascular, INC. | $86.03 | 2021-2025 | Denali Vena Cava Filter |
| Kiniksa Pharmaceuticals International, Plc | $49.54 | 2024 | Arcalyst |
| Endovascular Engineering INC. | $48.81 | 2024 | Helo Thrombectomy System |
| Bayer Healthcare Pharmaceuticals INC. | $46.10 | 2025 | |
| Philips North America LLC | $36.22 | 2022-2023 | |
| Heartflow, INC. | $35.37 | 2025 | |
| Impulse Dynamics (USA) INC. | $32.14 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $22.71 | 2025 | Evkeeza |
| Glaxosmithkline, LLC. | $20.08 | 2025 | Shingrix, Arexvy |
| Novo Nordisk INC | $17.80 | 2024 | Wegovy |
| Kiniksa Pharmaceuticals, LTD. | $12.92 | 2023 | Arcalyst |
| Terumo Medical Corporation | $12.85 | 2023 | Glidewire |
| Irhythm Technologies, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John-Paul Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.